Role of tumor-associated gangliosides in cancer progression

S Birklé1, G Zeng, L Gao

  • 1Ecole Nationale Vétérinaire, Nantes, France.

Biochimie
|May 29, 2003
PubMed

Insights

Gangliosides, a type of glycosphingolipid antigen, play crucial roles in neuroectodermal tumor progression by influencing immune suppression, angiogenesis, and metastasis. Further research into these sialylated molecules is essential.

Area of Science:

  • Oncology
  • Immunology
  • Biochemistry

Background:

  • Neuroectodermal tumors often express tumor-associated glycosphingolipid antigens, particularly gangliosides.
  • Gangliosides are increasingly recognized for their ability to modulate the biological effects of trophic factors and signaling pathways.

Purpose of the Study:

  • To revisit and elucidate the multifaceted functional roles of gangliosides in the progression of neuroectodermal tumors.
  • To highlight the importance of gangliosides in tumor-associated immune responses, angiogenesis, metastasis, and signal transduction.

Main Methods:

  • Review and synthesis of existing evidence on ganglioside functions in tumor biology.
  • Analysis of ganglioside interactions with cell surface molecules, transducer molecules, and kinases.

Main Results:

  • Gangliosides act as immunosuppressors by inhibiting cytotoxic T cells and dendritic cells.
  • Specific gangliosides (e.g., GD3, GM2) promote tumor angiogenesis.
  • Gangliosides regulate cell adhesion and motility, driving tumor metastasis.
  • Ganglioside antigens modulate signal transduction pathways, including those involving tyrosine kinases and growth factor receptors.

Conclusions:

  • Gangliosides are critical regulators of key processes in neuroectodermal tumor progression.
  • Their roles in immunosuppression, angiogenesis, metastasis, and signal transduction underscore their significance.
  • Further investigation into sialylated gangliosides is warranted to understand their in vivo biological behavior and therapeutic potential.

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...